Theralase Technologies (TSXV TLT) Revenue and Competitors

Toronto, ON CAN

Location

#7626

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • Theralase Technologies (TSXV TLT)'s estimated annual revenue is currently $2.9M per year.(i)
  • Theralase Technologies (TSXV TLT)'s estimated revenue per employee is $100,500

Employee Data

  • Theralase Technologies (TSXV TLT) has 29 Employees.(i)
  • Theralase Technologies (TSXV TLT) grew their employee count by 7% last year.

Theralase Technologies (TSXV TLT)'s People

NameTitleEmail/Phone
1
President and CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
Director Global SalesReveal Email/Phone
4
Engineering ManagerReveal Email/Phone
5
Research TechnicianReveal Email/Phone
6
Electronics TechnicianReveal Email/Phone
7
AccountantReveal Email/Phone
8
Product Development Scientist (Cancer therapy - Immunotherapy)Reveal Email/Phone
9
Electronics Engineering TechnologistReveal Email/Phone
10
Software and Firmware Design EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.5M92-1%N/AN/A
#2
$14.3M716%N/AN/A
#3
$36M1798%N/AN/A
#4
$7.8M398%N/AN/A
#5
$17.9M933%$192.2MN/A
#6
$64.9M3234%N/AN/A
#7
$0.5M5-55%N/AN/A
#8
$6.8M34-41%N/AN/A
#9
$19.5M9723%N/AN/A
#10
$2.5M2519%N/AN/A
Add Company

What Is Theralase Technologies (TSXV TLT)?

Theralase® Technologies is a Canadian clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers. We strive to continuously improve the quality of life for those afflicted with cancer by focusing our research and development on preventing, alleviating and treating diseases. Serving our higher purpose to bring hope for cancer treatments to light.Founded in 1994, Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the research and development of laser-based technologies for the destruction of cancer cells and other disease states. Theralase® is focused on the discovering, developing and aiming for commercialization of Anti-Cancer therapies using light-activated PhotoDynamic Compounds and their associated drug formulations to safely and effectively treat patients afflicted with cancer.

keywords:N/A

N/A

Total Funding

29

Number of Employees

$2.9M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M29-9%N/A
#2
$6.6M29-9%N/A
#3
$2.9M290%N/A
#4
$5M29-29%N/A
#5
$6.7M29-33%N/A